Vigilant Agilia, Vigilant Drug'Lib, REF Z073476, versions 1.0 and 1.1 Product Usage: Vigilant...
FDA Device Recall #Z-2065-2019 — Class I — June 24, 2019
Recall Summary
| Recall Number | Z-2065-2019 |
| Classification | Class I — Serious risk |
| Date Initiated | June 24, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fenwal Inc |
| Location | Lake Zurich, IL |
| Product Type | Devices |
| Quantity | 83 units |
Product Description
Vigilant Agilia, Vigilant Drug'Lib, REF Z073476, versions 1.0 and 1.1 Product Usage: Vigilant Drug Lib is Dose Error Reduction Software that, when used in combination with Volumat MC Agilia infusion pumps, is intended to reduce drug administration errors at the bedside. Vigilant Drug Lib Agilia is a software application running on a computer and intended to configure and generate multiple device configurations, drug libraries, care areas and data sets that can then be uploaded to the Volumat MC Agilia infusion pumps. Intended patient population: The Vigilant Drug Lib software must only be used to create drug libraries for patients whose weight is 250g to 250 kg (0.6 lbs. to 551 lbs.).
Reason for Recall
The firm is correcting four software anomalies and KVO (keep vein open) end of infusion alarm priority in Software versions 1.7 and 1.9a of Volumat MC Agilia Software and versions 1.0 and 1.1 of Vigilant DrugLib
Distribution Pattern
US Nationwide Distribution
Lot / Code Information
All serial numbers distributed in the US
Other Recalls from Fenwal Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1255-2023 | Class II | Amicus Exchange Kit Therapeutics. Component of ... | Feb 14, 2023 |
| Z-1254-2023 | Class II | Amicus MNC Apheresis Kit Double Needle. Compo... | Feb 14, 2023 |
| Z-1344-2021 | Class II | Amicus Exchange Kit - Product Usage: intended f... | Feb 25, 2021 |
| Z-1343-2021 | Class II | Amicus MNC Apheresis Kit - Double Needle - Prod... | Feb 25, 2021 |
| Z-1345-2021 | Class II | Amicus Exchange Kit Therapeutics - Product Usag... | Feb 25, 2021 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.